We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+4.79%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$9.92B
AUM Growth
+$227M
Cap. Flow
-$128M
Cap. Flow %
-1.29%
Top 10 Hldgs %
23.77%
Holding
295
New
45
Increased
130
Reduced
64
Closed
40

Top Buys

Rank Stock Value
1
ACGL icon
Arch Capital
ACGL
+$79.5M
2
INTC icon
Intel
INTC
+$77.4M
3
HCA icon
HCA Healthcare
HCA
+$66M
4
MO icon
Altria Group
MO
+$62.4M
5
MRK icon
Merck
MRK
+$53.5M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$171M
2
VR
Validus Hold Ltd
VR
+$156M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$76.7M
4
UNH icon
UnitedHealth
UNH
+$62.8M
5
NKTR icon
Nektar Therapeutics
NKTR
+$60.8M

Sector Composition

Rank Sector Weight
1 Technology 23.04%
2 Financials 22.63%
3 Healthcare 19.22%
4 Communication Services 10.44%
5 Industrials 7.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HMSY
226
DELISTED
HMS Holdings Corp.
HMSY
$3.12M 0.03%
185,000
– –
NSTG
227
DELISTED
NanoString Technologies, Inc.
NSTG
$2.94M 0.03%
391,919
+191,919
+96% +$1.39M
VIVE
228
DELISTED
VIVEVE MED INC
VIVE
$2.93M 0.03%
+800
New +$3.48M
CHGG icon
229
Chegg
CHGG
$116M
$2.93M 0.03%
+141,694
New +$2.68M
DCPH
230
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$2.76M 0.03%
137,700
-112,300
-45% -$2.84M
ADI icon
231
Analog Devices
ADI
$172B
$2.52M 0.03%
27,688
+4,027
+17% +$367K
HDB icon
232
HDFC Bank
HDB
$123B
$2.5M 0.03%
101,416
+1,612
+2% +$40.6K
VRNS icon
233
Varonis Systems
VRNS
$4.67B
$2.48M 0.03%
123,042
-106,500
-46% -$1.97M
ADVM
234
DELISTED
Adverum Biotechnologies
ADVM
$2.32M 0.02%
+40,000
New +$2.49M
VRNA
235
DELISTED
Verona Pharma
VRNA
$2M 0.02%
100,000
+4,851
+5% +$70.1K
KVHI icon
236
KVH Industries
KVHI
$171M
$1.9M 0.02%
185,397
+2,900
+2% +$31K
MDB icon
237
MongoDB
MDB
$25.8B
$1.74M 0.02%
40,000
+20,000
+100% +$646K
MTLS
238
Materialise
MTLS
$366M
$1.64M 0.02%
141,662
– –
AERI
239
DELISTED
Aerie Pharmaceuticals
AERI
$1.63M 0.02%
30,000
-70,000
-70% -$3.92M
CBAY
240
DELISTED
Cymabay Therapeutics
CBAY
$1.3M 0.01%
100,000
-150,000
-60% -$1.86M
DESP
241
DELISTED
Despegar.com
DESP
$1.19M 0.01%
38,136
+16,136
+73% +$481K
GS icon
242
Goldman Sachs
GS
$289B
$1M 0.01%
+3,980
New +$1.04M
EFSC icon
243
Enterprise Financial Services Corp
EFSC
$2.4B
$909K 0.01%
19,392
+1,149
+6% +$54.9K
HTT
244
High Templar Tech Ltd
HTT
$370M
$653K 0.01%
55,832
+29,986
+116% +$408K
VIPS icon
245
Vipshop
VIPS
$7.26B
$468K ﹤0.01%
+28,188
New +$466K
ESQ icon
246
Esquire Financial Holdings
ESQ
$1.14B
$435K ﹤0.01%
+17,844
New +$396K
AIFU
247
AIFU Inc
AIFU
$193M
$210K ﹤0.01%
+19
New +$216K
ACAD icon
248
Acadia Pharmaceuticals
ACAD
$4.51B
– –
-50,000
Closed -$1.51M
ADSK icon
249
Autodesk
ADSK
$51.8B
– –
-37,935
Closed -$3.98M
ANAB icon
250
AnaptysBio
ANAB
$1.54B
– –
-25,000
Closed -$2.52M
8 9
10
11 12

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q1 2018 Portfolio in Review

As of Q1 2018, Polar Capital held 295 positions worth $9.92B, up 2.3% from $9.69B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Polar Capital's Q1 2018 filing shows 45 new, 130 increased, 64 reduced and 40 closed positions. Its largest new stake was Intel: 1,627,806 shares worth $84.5M. The largest sale was Johnson & Johnson, an estimated $171M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Polar Capital's largest Q1 2018 buy was Intel: 1,627,806 shares worth $84.5M.
  • Polar Capital added most to Arch Capital in Q1 2018, an estimated $79.5M increase.
  • Polar Capital's biggest Q1 2018 reduction was Validus Hold Ltd, cutting an estimated $156M.
  • Polar Capital fully exited Johnson & Johnson in Q1 2018, selling an estimated $171M.
  • Polar Capital's ten largest holdings make up 24% of its $9.92B portfolio in Q1 2018.
  • Polar Capital opened 45 new positions and closed 40 in Q1 2018.
  • Polar Capital's portfolio value rose 2.3% quarter-over-quarter to $9.92B.

Based on Polar Capital's 13F filing for Q1 2018, filed 15 May 2018.